Literature DB >> 1730636

Post-translational regulation of macrophage apoprotein E production.

T Mazzone1, L Pustelnikas, C A Reardon.   

Abstract

We have transfected the murine macrophage cell line, J774, which does not express its endogenous apoE gene, with a constitutively expressed human apoE cDNA in order to study post-transcriptional and post-translational control of apoE production in macrophages. Loading cells with cholesterol using preincubations in acetylated low density lipoprotein, previously shown to enhance macrophage apoE gene transcription and apoE synthesis, did not increase apoE synthesis or secretion in constitutively expressing transfected cells, suggesting that sterol control of macrophage apoE production occurs predominantly at a transcriptional locus. However, incubation in human high density lipoprotein (HDL3) stimulated apoE secretion and appeared to inhibit degradation of newly synthesized apoE. This effect could be entirely reproduced by incubation with phosphatidylcholine vesicles which increased apoE accumulation in the medium by 2-6-fold. Pulse-chase experiments indicated that the effect of HDL3 or phospholipid vesicles was very rapid (occurring within 15 min) and was independent of changes in apoE synthesis. Furthermore, the increased apoE which accumulated in the medium in the presence of phospholipid vesicles or HDL3 was not due to altered rates of reuptake of labeled apoE since this difference was completely preserved in the absence of extracellular calcium. These results indicate that alteration of sterol content does not regulate macrophage apoE production at a translational or post-translational locus but that incubation with HDL3 or phospholipid vesicles can enhance apoprotein E production independent of changes in apoE gene transcription or apoE synthesis. The nature of the signal generated by the phospholipid vesicles which leads to inhibition of intracellular apoE degradation and enhanced apoE secretion will require further investigation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730636

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Expression of the human apoE2 isoform in adipocytes: altered cellular processing and impaired adipocyte lipogenesis.

Authors:  Zhi H Huang; Nobuyo Maeda; Theodore Mazzone
Journal:  J Lipid Res       Date:  2011-07-08       Impact factor: 5.922

2.  Endogenous adipocyte apolipoprotein E is colocalized with caveolin at the adipocyte plasma membrane.

Authors:  Lili Yue; Theodore Mazzone
Journal:  J Lipid Res       Date:  2010-12-16       Impact factor: 5.922

Review 3.  The key role of apolipoprotein E in atherosclerosis.

Authors:  Kirsty Greenow; Nigel J Pearce; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2005-04-13       Impact factor: 4.599

4.  Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages.

Authors:  P Cullen; A Cignarella; B Brennhausen; S Mohr; G Assmann; A von Eckardstein
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

5.  Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms.

Authors:  K Brand; N Mackman; L K Curtiss
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Tumor necrosis factor-alpha modulates monocyte/macrophage apoprotein E gene expression.

Authors:  H Duan; Z Li; T Mazzone
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

7.  Post-transcriptional regulation of apolipoprotein E expression in mouse macrophages by phorbol ester.

Authors:  L Dory
Journal:  Biochem J       Date:  1993-05-15       Impact factor: 3.857

8.  Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies.

Authors:  Wijtske Annema; Uwe Jf Tietge
Journal:  Nutr Metab (Lond)       Date:  2012-03-29       Impact factor: 4.169

Review 9.  Apoprotein E and Reverse Cholesterol Transport.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Int J Mol Sci       Date:  2018-11-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.